- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/487 - Physical analysis of biological material of liquid biological material
Patent holdings for IPC class G01N 33/487
Total number of patents in this class: 5386
10-year publication summary
399
|
500
|
515
|
457
|
440
|
425
|
360
|
315
|
290
|
212
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Roche Sequencing Solutions, Inc. | 660 |
219 |
F. Hoffmann-La Roche AG | 7948 |
198 |
Roche Diagnostics GmbH | 2695 |
130 |
Oxford NanoPore Technologies plc | 335 |
105 |
The Regents of the University of California | 20108 |
96 |
Ascensia Diabetes Care Holdings AG | 599 |
80 |
Abbott Diabetes Care Inc. | 2042 |
74 |
Roche Diabetes Care, Inc. | 1503 |
73 |
Oxford NanoPore Technologies Limited | 272 |
72 |
President and Fellows of Harvard College | 6002 |
56 |
Illumina, Inc. | 3381 |
56 |
Bayer HealthCare LLC | 1352 |
53 |
Siemens Healthcare Diagnostics Inc. | 2081 |
49 |
Arizona Board of Regents on behalf of Arizona State University | 2673 |
44 |
PHC Holdings Corporation | 720 |
42 |
Roche Diagnostics Operations, Inc. | 1502 |
40 |
International Business Machines Corporation | 61537 |
38 |
LifeScan Scotland Limited | 114 |
30 |
University of Washington | 2355 |
27 |
The Trustees of Columbia University in the City of New York | 3589 |
26 |
Other owners | 3878 |